Aminobenzoic acids and derivatives
Chemscene Dithiodipropionic acid | 25g | CS-W015111 | 98% | 1119-62-6 | MFCD00002780 | 210 26 | C6H10O4S2
Chemscene | Dithiodipropionic acid | 25g | CS-W015111 | 98% | 1119-62-6 | MFCD00002780 | 210 26 | C6H10O4S2
Chemscene Benzylideneacetone | 1kg | CS-W013311 | 98% | 122-57-6 | MFCD00008779 | 146 19 | C10H10O
Chemscene | Benzylideneacetone | 1kg | CS-W013311 | 98% | 122-57-6 | MFCD00008779 | 146 19 | C10H10O
Chemscene Boc-isoleucinol | 25g | CS-W014810 | 97% | 106946-74-1 | MFCD00235929 | 217 31 | C11H23NO3
Chemscene | Boc-isoleucinol | 25g | CS-W014810 | 97% | 106946-74-1 | MFCD00235929 | 217 31 | C11H23NO3
Chemscene Fmoc-N-Me-Thr(tBu)-OH | 25g | CS-W014461 | 98% | 117106-20-4 | MFCD02094431 | 411 49 | C24H29NO5
Chemscene | Fmoc-N-Me-Thr(tBu)-OH | 25g | CS-W014461 | 98% | 117106-20-4 | MFCD02094431 | 411 49 | C24H29NO5
Chemscene (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hexanoic acid | 5g | CS-W008492 | 98% | 112883-42-8 | MFCD00235878 | 367 44 | C22H25NO4
Chemscene | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hexanoic acid | 5g | CS-W008492 | 98% | 112883-42-8 | MFCD00235878 | 367 44 | C22H25NO4
Chemscene N-Methylpyridin-4-amine | 500g | CS-W013674 | 98% | 1121-58-0 | MFCD00152625 | 108 14 | C6H8N2
Chemscene | N-Methylpyridin-4-amine | 500g | CS-W013674 | 98% | 1121-58-0 | MFCD00152625 | 108 14 | C6H8N2
Chemscene 2 5-Pyridinedicarboxylic acid | 25g | CS-W013239 | 98% | 100-26-5 | MFCD00006297 | 167 12 | C7H5NO4
Chemscene | 2 5-Pyridinedicarboxylic acid | 25g | CS-W013239 | 98% | 100-26-5 | MFCD00006297 | 167 12 | C7H5NO4
Chemscene (4S 4 S)-2 2 -(Propane-2 2-diyl)bis(4-phenyl-4 5-dihydrooxazole) | 250mg | CS-W014499 | 98% | 131457-46-0 | MFCD00192245 | 334 42 | C21H22N2O2
Chemscene | (4S 4 S)-2 2 -(Propane-2 2-diyl)bis(4-phenyl-4 5-dihydrooxazole) | 250mg | CS-W014499 | 98% | 131457-46-0 | MFCD00192245 | 334 42 | C21H22N2O2
Chemscene Dibenzo[b d]thiophene 5 5-dioxide | 25g | CS-W014845 | 98% | 1016-05-3 | MFCD00004970 | 216 26 | C12H8O2S
Chemscene | Dibenzo[b d]thiophene 5 5-dioxide | 25g | CS-W014845 | 98% | 1016-05-3 | MFCD00004970 | 216 26 | C12H8O2S
Chemscene Dithiodipropionic acid | 500g | CS-W015111 | 98% | 1119-62-6 | MFCD00002780 | 210 26 | C6H10O4S2
Chemscene | Dithiodipropionic acid | 500g | CS-W015111 | 98% | 1119-62-6 | MFCD00002780 | 210 26 | C6H10O4S2
Sigma Aldrich Fine Chemicals Biosciences UKBi011 A Human iPS Cell L
Induced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell-like state. The cells can replicate indefinitely or under controlled conditions can be differentiated into any other cell type such as nerve heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.The EBiSC stem cell bank is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease Parkinsons Disease Dementia Motor Neuron Diseas
